INFU
InfuSystem Holdings, Inc.
Price Chart
Latest Quote
$9.21
+0.06 (+0.66%)
Current Price
| Previous Close | $9.15 |
| Open | $9.18 |
| Day High | $9.26 |
| Day Low | $8.99 |
| Volume | 33,730 |
Stock Information
| Shares Outstanding | 20.18M |
| Total Debt | $24.10M |
| Cash Equivalents | $2.11M |
| Revenue | $142.40M |
| Net Income | $7.91M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $185.87M |
| P/E Ratio | 24.89 |
| EPS (TTM) | $0.37 |
| Exchange | ASE |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $206.66M |
| Sales | $142.40M |
| Income | $7.91M |
| Book/sh | $2.91 |
| Cash/sh | $0.10 |
| Employees | 461 |
Financial Ratios
| Quick Ratio | 1.59 |
| Current Ratio | 2.14 |
| Debt/Eq | 41.03 |
Returns & Margins
| ROA | 6.71% |
| ROE | 13.89% |
| Gross Margin | 56.75% |
| Operating Margin | 4.72% |
| Profit Margin | 5.55% |
Ownership
| Insider Ownership | 7.15% |
| Institutional Ownership | 78.24% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 20.93 |
| PEG | 1.73 |
| P/S | 1.31 |
| P/B | 3.16 |
Analyst Data
| Recommendation | none |
| Target Price | $14.88 |
Technical Indicators
| SMA20 | $9.03 |
| SMA50 | $9.46 |
| SMA200 | $9.33 |
| RSI | 51.74 |
| ATR | 0.3650 |
| Shares Float | 18.52M |
| Short Float | 0.86% |
| Short Ratio | 0.66 |
| Volatility | 1.42 |
| Rel Volume | 0.24 |
Performance History
| Week | +5.26% |
| Month | -3.15% |
| Quarter | -5.92% |
| 6 Months | +0.55% |
| YTD | +9.77% |
| Year | +47.12% |
| 3 Years | -9.71% |
| 5 Years | -52.18% |
| 10 Years | +241.11% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $9.21 | 33,730 |
| 2026-06-24 | $9.15 | 78,400 |
| 2026-06-23 | $9.08 | 118,300 |
| 2026-06-22 | $8.92 | 135,700 |
| 2026-06-18 | $9.42 | 201,500 |
| 2026-06-17 | $8.75 | 119,800 |
| 2026-06-16 | $8.80 | 268,700 |
| 2026-06-15 | $8.80 | 135,800 |
| 2026-06-12 | $9.14 | 157,700 |
| 2026-06-11 | $9.05 | 148,400 |
| 2026-06-10 | $8.88 | 111,300 |
| 2026-06-09 | $9.01 | 162,700 |
| 2026-06-08 | $9.01 | 94,100 |
| 2026-06-05 | $9.24 | 98,000 |
| 2026-06-04 | $9.12 | 99,600 |
| 2026-06-03 | $9.03 | 128,300 |
| 2026-06-02 | $8.88 | 214,200 |
| 2026-06-01 | $8.95 | 156,700 |
| 2026-05-29 | $9.07 | 163,200 |
| 2026-05-28 | $9.06 | 138,000 |
| 2026-05-27 | $9.25 | 181,900 |
| 2026-05-26 | $9.51 | 159,200 |
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
đ° Latest News
Should Value Investors Buy InfuSystems Holdings (INFU) Stock?
Zacks âĸ 2026-06-12T13:40:03Z
Does InfuSystems Holdings (INFU) Have the Potential to Rally 62.61% as Wall Street Analysts Expect?
Zacks âĸ 2026-06-05T13:55:04Z
Here is Why Growth Investors Should Buy InfuSystems Holdings (INFU) Now
Zacks âĸ 2026-06-04T16:45:03Z
Are Investors Undervaluing InfuSystems Holdings (INFU) Right Now?
Zacks âĸ 2026-05-27T13:40:04Z
Looking for a Growth Stock? 3 Reasons Why InfuSystems Holdings (INFU) is a Solid Choice
Zacks âĸ 2026-05-19T16:45:02Z
Is InfuSystems Holdings (INFU) Stock Undervalued Right Now?
Zacks âĸ 2026-05-11T13:40:08Z
InfuSystem Holdings, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-07T20:57:40Z
InfuSystems Holdings, Inc. (INFU) Q1 Earnings Top Estimates
Zacks âĸ 2026-05-07T11:45:06Z
InfuSystems Holdings Inc (INFU) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
GuruFocus.com âĸ 2026-02-26T01:02:07ZInfuSystem Holdings, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-02-24T21:32:30Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $50,766,000 | $52,950,000 | $51,158,000 | $38,488,000 |
| Cost Of Revenue | $63,140,000 | $64,458,000 | $62,676,000 | $49,354,000 |
| Total Revenue | $143,436,000 | $134,861,000 | $125,785,000 | $109,914,000 |
| Operating Revenue | $143,436,000 | $134,861,000 | $125,785,000 | $109,914,000 |
| Expenses | ||||
| Interest Expense | $1,299,000 | $1,777,000 | $2,170,000 | $1,402,000 |
| Total Expenses | $131,516,000 | $127,970,000 | $121,697,000 | $108,260,000 |
| Other Income Expense | $2,000 | $-55,000 | $-67,000 | $-122,000 |
| Other Non Operating Income Expenses | $2,000 | $-55,000 | $-67,000 | $-122,000 |
| Net Non Operating Interest Income Expense | $-1,299,000 | $-1,777,000 | $-2,170,000 | $-1,402,000 |
| Interest Expense Non Operating | $1,299,000 | $1,777,000 | $2,170,000 | $1,402,000 |
| Operating Expense | $68,376,000 | $63,512,000 | $59,021,000 | $58,906,000 |
| Selling And Marketing Expense | $10,487,000 | $11,312,000 | $12,654,000 | $12,259,000 |
| General And Administrative Expense | $56,969,000 | $51,209,000 | $45,377,000 | $44,153,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $6,627,000 | $2,345,000 | $872,000 | $18,000 |
| Net Interest Income | $-1,299,000 | $-1,777,000 | $-2,170,000 | $-1,402,000 |
| Normalized Income | $6,627,000 | $2,345,000 | $872,000 | $18,000 |
| Net Income From Continuing And Discontinued Operation | $6,627,000 | $2,345,000 | $872,000 | $18,000 |
| Total Operating Income As Reported | $11,920,000 | $6,891,000 | $4,088,000 | $1,654,000 |
| Net Income Common Stockholders | $6,627,000 | $2,345,000 | $872,000 | $18,000 |
| Net Income | $6,627,000 | $2,345,000 | $872,000 | $18,000 |
| Net Income Including Noncontrolling Interests | $6,627,000 | $2,345,000 | $872,000 | $18,000 |
| Net Income Continuous Operations | $6,627,000 | $2,345,000 | $872,000 | $18,000 |
| Pretax Income | $10,623,000 | $5,059,000 | $1,851,000 | $130,000 |
| Operating Income | $11,920,000 | $6,891,000 | $4,088,000 | $1,654,000 |
| Depreciation Amortization Depletion Income Statement | $920,000 | $991,000 | $990,000 | $2,494,000 |
| Depreciation And Amortization In Income Statement | $920,000 | $991,000 | $990,000 | $2,494,000 |
| Amortization Of Intangibles Income Statement | $920,000 | $991,000 | $990,000 | $2,494,000 |
| Gross Profit | $80,296,000 | $70,403,000 | $63,109,000 | $60,560,000 |
| Per Share | ||||
| Diluted EPS | $0.31 | $0.11 | $0.04 | $0.00 |
| Basic EPS | $0.32 | $0.11 | $0.04 | $0.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $25,216,000 | $19,335,000 | $16,529,000 | $14,892,000 |
| Reconciled Depreciation | $13,294,000 | $12,499,000 | $12,508,000 | $13,360,000 |
| EBITDA (Bullshit earnings) | $25,216,000 | $19,335,000 | $16,529,000 | $14,892,000 |
| EBIT | $11,922,000 | $6,836,000 | $4,021,000 | $1,532,000 |
| Diluted Average Shares | $21,097,323 | $21,707,151 | $21,646,079 | $21,547,306 |
| Basic Average Shares | $20,657,877 | $21,271,608 | $21,024,382 | $20,648,818 |
| Diluted NI Availto Com Stockholders | $6,627,000 | $2,345,000 | $872,000 | $18,000 |
| Tax Provision | $3,996,000 | $2,714,000 | $979,000 | $112,000 |
| Amortization | $920,000 | $991,000 | $990,000 | $2,494,000 |
| Selling General And Administration | $67,456,000 | $62,521,000 | $58,031,000 | $56,412,000 |
| Other Gand A | $56,969,000 | $51,209,000 | $45,377,000 | $44,153,000 |
| Provision For Doubtful Accounts | - | - | - | $87,000 |
Fetched: 2026-06-25
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $46,750,000 | $47,363,000 | $41,146,000 | $35,857,000 |
| Total Assets | $100,560,000 | $103,614,000 | $102,915,000 | $99,388,000 |
| Total Non Current Assets | $64,224,000 | $71,449,000 | $72,295,000 | $74,609,000 |
| Other Non Current Assets | $6,267,000 | $4,035,000 | $4,630,000 | $2,870,000 |
| Non Current Deferred Assets | $4,640,000 | $7,188,000 | $9,115,000 | $9,625,000 |
| Non Current Deferred Taxes Assets | $4,640,000 | $7,188,000 | $9,115,000 | $9,625,000 |
| Financial Assets | $748,000 | $1,481,000 | $1,442,000 | $1,965,000 |
| Goodwill And Other Intangible Assets | $10,576,000 | $10,166,000 | $11,156,000 | $12,146,000 |
| Other Intangible Assets | $6,866,000 | $6,456,000 | $7,446,000 | $8,436,000 |
| Current Assets | $36,336,000 | $32,165,000 | $30,620,000 | $24,779,000 |
| Other Current Assets | $4,858,000 | $3,955,000 | $4,157,000 | $2,922,000 |
| Inventory | $5,391,000 | $6,528,000 | $6,402,000 | $4,821,000 |
| Receivables | $22,901,000 | $21,155,000 | $19,830,000 | $16,871,000 |
| Accounts Receivable | $22,901,000 | $21,155,000 | $19,830,000 | $16,871,000 |
| Allowance For Doubtful Accounts Receivable | $-300,000 | $-200,000 | $-600,000 | $-1,100,000 |
| Gross Accounts Receivable | $23,201,000 | $21,355,000 | $20,430,000 | $17,971,000 |
| Cash Cash Equivalents And Short Term Investments | $3,186,000 | $527,000 | $231,000 | $165,000 |
| Cash And Cash Equivalents | $3,186,000 | $527,000 | $231,000 | $165,000 |
| Debt | ||||
| Net Debt | $16,439,000 | $23,337,000 | $28,870,000 | $32,992,000 |
| Total Debt | $23,052,000 | $28,424,000 | $34,900,000 | $36,918,000 |
| Long Term Debt And Capital Lease Obligation | $23,052,000 | $28,424,000 | $34,900,000 | $36,918,000 |
| Long Term Debt | $19,625,000 | $23,864,000 | $29,101,000 | $33,157,000 |
| Current Debt And Capital Lease Obligation | - | - | - | - |
| Current Debt | - | - | - | - |
| Other Current Borrowings | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $43,234,000 | $46,085,000 | $50,613,000 | $51,385,000 |
| Total Non Current Liabilities Net Minority Interest | $23,052,000 | $28,424,000 | $34,900,000 | $36,918,000 |
| Current Liabilities | $20,182,000 | $17,661,000 | $15,713,000 | $14,467,000 |
| Other Current Liabilities | $9,361,000 | $7,813,000 | $7,704,000 | $6,126,000 |
| Payables And Accrued Expenses | $10,821,000 | $9,848,000 | $8,009,000 | $8,341,000 |
| Payables | $10,821,000 | $9,848,000 | $8,009,000 | $8,341,000 |
| Accounts Payable | $10,821,000 | $9,848,000 | $8,009,000 | $8,341,000 |
| Equity | ||||
| Common Stock Equity | $57,326,000 | $57,529,000 | $52,302,000 | $48,003,000 |
| Total Equity Gross Minority Interest | $57,326,000 | $57,529,000 | $52,302,000 | $48,003,000 |
| Stockholders Equity | $57,326,000 | $57,529,000 | $52,302,000 | $48,003,000 |
| Gains Losses Not Affecting Retained Earnings | $565,000 | $1,119,000 | $1,088,000 | $1,489,000 |
| Other Equity Adjustments | $565,000 | $1,119,000 | $1,088,000 | $1,489,000 |
| Retained Earnings | $-60,702,000 | $-57,460,000 | $-58,625,000 | $-59,344,000 |
| Other | ||||
| Ordinary Shares Number | $20,209,636 | $21,272,351 | $21,196,851 | $20,781,977 |
| Share Issued | $20,209,636 | $21,272,351 | $21,196,851 | $20,781,977 |
| Tangible Book Value | $46,750,000 | $47,363,000 | $41,146,000 | $35,857,000 |
| Invested Capital | $76,951,000 | $81,393,000 | $81,403,000 | $81,160,000 |
| Working Capital | $16,154,000 | $14,504,000 | $14,907,000 | $10,312,000 |
| Capital Lease Obligations | $3,427,000 | $4,560,000 | $5,799,000 | $3,761,000 |
| Total Capitalization | $76,951,000 | $81,393,000 | $81,403,000 | $81,160,000 |
| Additional Paid In Capital | $117,461,000 | $113,868,000 | $109,837,000 | $105,856,000 |
| Capital Stock | $2,000 | $2,000 | $2,000 | $2,000 |
| Common Stock | $2,000 | $2,000 | $2,000 | $2,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $3,427,000 | $4,560,000 | $5,799,000 | $3,761,000 |
| Goodwill | $3,710,000 | $3,710,000 | $3,710,000 | $3,710,000 |
| Net PPE | $41,993,000 | $48,579,000 | $45,952,000 | $48,003,000 |
| Accumulated Depreciation | $-80,041,000 | $-72,471,000 | $-65,191,000 | $-62,353,000 |
| Gross PPE | $122,034,000 | $121,050,000 | $111,143,000 | $110,356,000 |
| Leases | $5,099,000 | $4,911,000 | $3,570,000 | $3,498,000 |
| Other Properties | $110,511,000 | $109,872,000 | $100,875,000 | $101,061,000 |
| Machinery Furniture Equipment | $6,424,000 | $6,267,000 | $6,698,000 | $5,797,000 |
| Properties | $0 | $0 | $0 | $0 |
Fetched: 2026-06-25
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $15,722,000 | $2,626,000 | $106,000 | $2,441,000 |
| Operating Activities | ||||
| Operating Cash Flow | $24,408,000 | $20,459,000 | $11,223,000 | $17,517,000 |
| Cash Flow From Continuing Operating Activities | $24,408,000 | $20,459,000 | $11,223,000 | $17,517,000 |
| Operating Gains Losses | $-2,789,000 | $-1,326,000 | $-1,161,000 | $-250,000 |
| Investing Activities | ||||
| Capital Expenditure | $-8,686,000 | $-17,833,000 | $-11,117,000 | $-15,076,000 |
| Investing Cash Flow | $-6,790,000 | $-13,239,000 | $-6,734,000 | $-11,478,000 |
| Cash Flow From Continuing Investing Activities | $-6,790,000 | $-13,239,000 | $-6,734,000 | $-11,478,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-10,974,000 | $-1,996,000 | $-1,311,000 | $-6,652,000 |
| Financing Cash Flow | $-14,959,000 | $-6,924,000 | $-4,423,000 | $-6,060,000 |
| Cash Flow From Continuing Financing Activities | $-14,959,000 | $-6,924,000 | $-4,423,000 | $-6,060,000 |
| Net Other Financing Charges | $-197,000 | - | $-229,000 | $-750,000 |
| Net Common Stock Issuance | $-10,974,000 | $-1,996,000 | $-1,311,000 | $-6,652,000 |
| Other | ||||
| Repayment Of Debt | $-52,349,000 | $-56,113,000 | $-55,499,000 | $-42,035,000 |
| Issuance Of Debt | $48,226,000 | $50,798,000 | $51,552,000 | $42,022,000 |
| Interest Paid Supplemental Data | $1,243,000 | $1,749,000 | $2,052,000 | $1,310,000 |
| Income Tax Paid Supplemental Data | $543,000 | $753,000 | $213,000 | $153,000 |
| End Cash Position | $3,186,000 | $527,000 | $231,000 | $165,000 |
| Beginning Cash Position | $527,000 | $231,000 | $165,000 | $186,000 |
| Changes In Cash | $2,659,000 | $296,000 | $66,000 | $-21,000 |
| Proceeds From Stock Option Exercised | $335,000 | $387,000 | $1,064,000 | $1,355,000 |
| Common Stock Payments | $-10,974,000 | $-1,996,000 | $-1,311,000 | $-6,652,000 |
| Net Issuance Payments Of Debt | $-4,123,000 | $-5,315,000 | $-3,947,000 | $-13,000 |
| Net Long Term Debt Issuance | $-4,123,000 | $-5,315,000 | $-3,947,000 | $-13,000 |
| Long Term Debt Payments | $-52,349,000 | $-56,113,000 | $-55,499,000 | $-42,035,000 |
| Long Term Debt Issuance | $48,226,000 | $50,798,000 | $51,552,000 | $42,022,000 |
| Net Business Purchase And Sale | $-1,412,000 | $0 | $0 | $0 |
| Purchase Of Business | $-1,412,000 | $0 | $0 | $0 |
| Net PPE Purchase And Sale | $-5,378,000 | $-13,239,000 | $-6,734,000 | $-11,478,000 |
| Sale Of PPE | $3,308,000 | $4,594,000 | $4,383,000 | $3,598,000 |
| Purchase Of PPE | $-8,686,000 | $-17,833,000 | $-11,117,000 | $-15,076,000 |
| Change In Working Capital | $-94,000 | $652,000 | $-5,562,000 | $385,000 |
| Change In Other Current Assets | $-789,000 | $2,155,000 | $-4,033,000 | $-522,000 |
| Change In Payables And Accrued Expense | $-708,000 | $-676,000 | $2,415,000 | $2,942,000 |
| Change In Payable | $-708,000 | $-676,000 | $2,415,000 | $2,942,000 |
| Change In Account Payable | $-708,000 | $-676,000 | $2,415,000 | $2,942,000 |
| Change In Inventory | $1,140,000 | $-126,000 | $-1,581,000 | $-882,000 |
| Change In Receivables | $263,000 | $-701,000 | $-2,363,000 | $-1,153,000 |
| Changes In Account Receivables | $263,000 | $-701,000 | $-2,363,000 | $-1,153,000 |
| Other Non Cash Items | $81,000 | $78,000 | $120,000 | $73,000 |
| Stock Based Compensation | $4,363,000 | $4,460,000 | $4,074,000 | $3,825,000 |
| Provisionand Write Offof Assets | $200,000 | $-167,000 | $-261,000 | $87,000 |
| Deferred Tax | $2,726,000 | $1,918,000 | $633,000 | $19,000 |
| Deferred Income Tax | $2,726,000 | $1,918,000 | $633,000 | $19,000 |
| Depreciation Amortization Depletion | $13,294,000 | $12,499,000 | $12,508,000 | $13,360,000 |
| Depreciation And Amortization | $13,294,000 | $12,499,000 | $12,508,000 | $13,360,000 |
| Amortization Cash Flow | $920,000 | $991,000 | $990,000 | $2,494,000 |
| Amortization Of Intangibles | $920,000 | $991,000 | $990,000 | $2,494,000 |
| Depreciation | $12,374,000 | $11,508,000 | $11,518,000 | $10,866,000 |
| Gain Loss On Sale Of PPE | $-2,789,000 | $-1,326,000 | $-1,161,000 | $-250,000 |
| Net Income From Continuing Operations | $6,627,000 | $2,345,000 | $872,000 | $18,000 |
Fetched: 2026-06-25